In what at first may appear to be an oversight, there isn’t a single mention of intellectual property law on the website bio of Stephanie Parker, the lawyer who led the team that achieved last week’s record-breaking $2.54 billion patent infringement verdict for client Idenix Pharmaceuticals.
But it was no blunder by the marketing team at Jones Day, where Parker is a partner. The co-head of the firm’s business and tort litigation group has dozens upon dozens of trials under her belt. But when it comes to intellectual property law, the epic patent battle between her Merck-subsidiary client and Gilead Sciences was Parker’s first attempt at an intellectual property case.
